title: Effect of glatiramer acetate (Copaxone) given orally in human patients: interleukin-10 production during a phase 1 trial.
authors.forename: J
authors.initials: J
authors.lastname: de Seze
authors.forename: G
authors.initials: G
authors.lastname: Edan
authors.forename: M
authors.initials: M
authors.lastname: Labalette
authors.forename: J P
authors.initials: JP
authors.lastname: Dessaint
authors.forename: P
authors.initials: P
authors.lastname: Vermersch
mesh_terms: D000276:Adjuvants, Immunologic / Q000494:pharmacology / Q000627:therapeutic use*; D000284:Administration, Oral; D016207:Cytokines / Q000096:biosynthesis; D004311:Double-Blind Method; D000068717:Glatiramer Acetate; D006801:Humans; D016753:Interleukin-10 / Q000096:biosynthesis*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000378:metabolism; D010455:Peptides / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D000276:Adjuvants, Immunologic; D016207:Cytokines; D010455:Peptides; D016753:Interleukin-10; D000068717:Glatiramer Acetate